EP2252283
Tilbúin tríterpenóíð og aðferðir við notkun í meðferð sjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.1.2009EP published:
28.11.2018EP application number:
09701279.3
EP translation filed:
10.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
11.1.2029Expiry date:
11.1.2026Next due date:
31.1.2026
Title:
SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE
Timeline
Today
12.1.2009EP application
28.11.2018EP Publication
10.1.2019Translation submitted
15.2.2019Registration published
11.1.2026Expires
Owner
Name:
Trustees of Dartmouth CollegeAddress:
11 Rope Ferry Road, 03766, Hanover, NH, US
Name:
Reata Pharmaceuticals Holdings, LLCAddress:
5320 Legacy Drive, Plano, Texas 75024, US
Inventor
Name:
SPORN, MichaelAddress:
TunbridgeVT, US
Name:
LIBY, KarenAddress:
West LebanonNH, US
Name:
GRIBBLE, Gordon, W.Address:
LebanonNH, US
Name:
HONDA, TadashiAddress:
HanoverNH, US
Name:
KRAL, Robert, M.Address:
GrapevineTX, US
Name:
MEYER, Colin, J.Address:
FriscoTX, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
20624 PDate:
11.1.2008Country:
US
Number:
109114 PDate:
28.10.2008Country:
US
Classification
Categories:
A61K 31/275, A61K 31/4164, A61P 3/00, A61P 9/00, A61K 31/277, A61K 31/4174
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 9.1.2019
Expires: 11.1.2020
Payer: Árnason Faktor
Number: 12
Paid: 14.1.2020
Expires: 11.1.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 29.12.2020
Expires: 11.1.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 28.12.2021
Expires: 11.1.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 28.12.2022
Expires: 11.1.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 27.12.2023
Expires: 11.1.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 27.12.2024
Expires: 11.1.2026
Payer: Árnason Faktor ehf.